Cologne Bonn Region
Senior executive with extensive experience in program and project leadership across clinical research and the development of highly complex medical devices and automated systems. Servant leader with a contemporary leadership philosophy, positioning leadership as a value-creating service—driving empowerment, trust, and sustainable organizational performance as a deliberate alternative to traditional hierarchical models. Proven track record in leading and scaling high-performing international, interdisciplinary, and cross-site development organizations.
Defined and executed segment strategy, aligning innovation, portfolio management, and commercial priorities to drive sustainable growth and market leadership. Led global, cross-functional organizations across R&D, operations, quality, and commercial functions, ensuring seamless end-to-end execution. Drove development and lifecycle management of complex system portfolios, translating customer and market needs into scalable, high-impact solutions. Established and maintained strong relationships with key stakeholders, including executive leadership, customers, partners, and regulatory bodies. Championed organizational transformation, fostering a high-performance, innovation-driven culture and enabling agile, efficient operating models. Oversaw resource allocation, investment planning, and risk management to ensure optimal return on investment and strategic goal achievement. Represented the business segment at executive and board level, providing strategic insights, performance transparency, and decision-making support.
Executive ownership of P&L and strategic program leadership for the company’s top-performing portfolio, driving sustainable growth and market leadership. Set and executed the strategic vision for next-generation system development across laboratory, clinical, and pharmaceutical domains, aligning innovation with business objectives
Led global new product development for automated clinical and pharmaceutical systems enabling the production of individualized cell therapies. Built and scaled high-performing, interdisciplinary, and international development organizations Defined, aligned, and communicated program strategy and objectives across internal and external stakeholders, including executive leadership and Managing Directors.